Please login to the form below

Not currently logged in
Email:
Password:

Therachon

This page shows the latest Therachon news and features for those working in and with pharma, biotech and healthcare.

Pfizer buys dwarfism drug company Therachon for $810m

Pfizer buys dwarfism drug company Therachon for $810m

Will rival BioMarin pipeline drug. Pfizer is spending $340m to acquire Therachon, a European biotech with a drug in trials for achondroplasia, a form of short-limbed dwarfism. ... By acquiring Therachon, we hope to leverage Pfizer’s leading scientific

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Therachon poaches Shire’s Aled Williams Therachon poaches Shire’s Aled Williams

    Therachon, a clinical-stage biotechnology company, has appointed Aled Williams to the position of chief commercial officer and head of patient access. ... in developing TA-46, and advancing Therachon’s pipeline of drug candidates that aim to bring a

  • Therachon appoints Christian Meyer as chief medical officer Therachon appoints Christian Meyer as chief medical officer

    He succeeds Maarten Kraan who remains as an advisor. Therachon has appointed Christian Meyer as its new chief medical officer, a role that will see him succeed Maarten Kraan, who will ... Luca Santarelli, chief executive officer and director, Therachon,

  • Therachon appoints new chief medical officer Therachon appoints new chief medical officer

    him focus on the clinical development of TA-46 - Therachon’s leading drug in development for achondroplasia. ... Luca Santarelli, chief medical officer at Therachon, said: “Dr Kraan’s wealth of translational and drug development expertise is

  • Therachon strengthens management team Therachon strengthens management team

    MacroGenics. Meanwhile, Dr Schikan (pictured below right) joins Therachon's board as a non-executive director. ... Dr Luca Santarelli, Therachon's chief executive officer and director, said: “I am delighted to have Drs Schikan, Porter and Stavenhagen

More from appointments
Approximately 4 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics